Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 56 min ago
PreprintAll rights reservedbioRxiv

IL-23 licenses the transition from preclinical autoimmunity to inflammatory arthritis through IL-17A-dependent mechanisms

  • M. Jarlborg1
  • A. Circiumaru
  • C. Lamacchia
  • L. Vaillant
  • E. Rakotoarijaonina
  • K. Venken
  • D. Elewaut
  • E. Rodriguez
  • A. Caruso
  • A. Huard
  • L. Santuari
  • N. Chammartin
5 more authors
  • D. S. Courvoisier
  • M. Andreatta
  • S. J. Carmona
  • A. Finckh
  • C. Gabay
  1. 1Division of Rheumatology, Department of Medicine and Department of Pathology and Immunology, Geneva Center of Inflammation Research, Faculty of Medicine, Univer
Read full textPDFDOICite

Related

  1. Dysbiosis-induced expansion of AXL-positive inflammatory type 3 dendritic cells triggers preclinical autoimmunity
    Grozdan Cvijetic, Valentina Ottaviani, Isabella Conway +32
    Nature ImmunologyPeer-reviewedCC BY 4.0Full text1 citedImmunologyHAL
  2. Interpreting immunoglobulin A evidence for the mucosal origins of rheumatoid arthritis autoimmunity
    Jilong Ma, Yong Wei, Wengxia Qi +3
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0ImmunologyFrontiersCrossref
  3. A pro-inflammatory effector-memory T cell program links peripheral EBV priming to CNS autoimmunity
    N. P. Kristensen, T. Tsaktanis, S. Frischholz +22
    bioRxivPreprintCC BY-NC-NDFull textImmunologybioRxiv
  4. T cells in type 1 diabetes: mechanisms of β-cell autoimmunity, innate-adaptive immune crosstalk, and translational immunotherapy
    Bushra Amer, Mohammed Alnukhali, Albaraa Haidarah +1
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0Full textGenetics & genomicsCrossrefEurope PMCPMCEurope PMC
  5. CAR-macrophage immunotherapy targeting fibroblast-like synoviocytes ameliorates inflammatory and degenerative arthritis
    Y. Xu, Z. Wang, D. Xie +3
    bioRxivPreprintAll rights reservedFull textSystems & synthetic biologybioRxiv

Cite

BibTeXRIS
BibTeX
@misc{jarlborg2026il23,
  title = {{IL-23 licenses the transition from preclinical autoimmunity to inflammatory arthritis through IL-17A-dependent mechanisms}},
  author = {M. Jarlborg and A. Circiumaru and C. Lamacchia and L. Vaillant and E. Rakotoarijaonina and K. Venken and D. Elewaut and E. Rodriguez and A. Caruso and A. Huard and L. Santuari and N. Chammartin and D. S. Courvoisier and M. Andreatta and S. J. Carmona and A. Finckh and C. Gabay},
  howpublished = {bioRxiv},
  year = {2026},
  month = oct,
  doi = {10.64898/2026.10.30.762860},
  url = {https://www.biorxiv.org/content/10.64898/2026.10.30.762860v1},
}
RIS
TY  - UNPB
TI  - IL-23 licenses the transition from preclinical autoimmunity to inflammatory arthritis through IL-17A-dependent mechanisms
AU  - M. Jarlborg
AU  - A. Circiumaru
AU  - C. Lamacchia
AU  - L. Vaillant
AU  - E. Rakotoarijaonina
AU  - K. Venken
AU  - D. Elewaut
AU  - E. Rodriguez
AU  - A. Caruso
AU  - A. Huard
AU  - L. Santuari
AU  - N. Chammartin
AU  - D. S. Courvoisier
AU  - M. Andreatta
AU  - S. J. Carmona
AU  - A. Finckh
AU  - C. Gabay
PY  - 2026
DA  - 2026/10/30
PB  - bioRxiv
DO  - 10.64898/2026.10.30.762860
UR  - https://www.biorxiv.org/content/10.64898/2026.10.30.762860v1
ER  -